000 | 01803 a2200529 4500 | ||
---|---|---|---|
005 | 20250516055846.0 | ||
264 | 0 | _c20120710 | |
008 | 201207s 0 0 eng d | ||
022 | _a1433-2981 | ||
024 | 7 |
_a10.1016/j.clon.2011.09.008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHan, K | |
245 | 0 | 0 |
_aExpression of HER2neu in ductal carcinoma in situ is associated with local recurrence. _h[electronic resource] |
260 |
_bClinical oncology (Royal College of Radiologists (Great Britain)) _cApr 2012 |
||
300 |
_a183-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
650 | 0 | 4 |
_aBreast Neoplasms _xmetabolism |
650 | 0 | 4 |
_aCarcinoma, Ductal, Breast _xmetabolism |
650 | 0 | 4 |
_aCarcinoma, Intraductal, Noninfiltrating _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMastectomy, Segmental |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Invasiveness |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdiagnosis |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
650 | 0 | 4 |
_aReceptors, Estrogen _xmetabolism |
650 | 0 | 4 |
_aReceptors, Progesterone _xmetabolism |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aNofech-Mozes, S | |
700 | 1 | _aNarod, S | |
700 | 1 | _aHanna, W | |
700 | 1 | _aVesprini, D | |
700 | 1 | _aSaskin, R | |
700 | 1 | _aTaylor, C | |
700 | 1 | _aKong, I | |
700 | 1 | _aPaszat, L | |
700 | 1 | _aRakovitch, E | |
773 | 0 |
_tClinical oncology (Royal College of Radiologists (Great Britain)) _gvol. 24 _gno. 3 _gp. 183-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clon.2011.09.008 _zAvailable from publisher's website |
999 |
_c21195455 _d21195455 |